Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |